NIC Inc. has been selected to provide its RxGov prescription drug monitoring platform to the State of Maryland to help combat the prescription opioid epidemic. Following a competitive, open procurement process, a five-year contract extending to 2025 was awarded to NIC by the regional health information exchange, the Chesapeake Regional Information System for Patients (CRISP). CRISP partners with the Maryland Department of Health to administer the Maryland Prescription Drug Monitoring Program (PDMP).